C07C 225/20
Compounds containing amino groups and doubly—bound oxygen atoms bound to the same
Official title: having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
C07C225/20 (Compounds containing amino groups and doubly—bound oxygen atoms bound to the same) appears on 156 US grants and 145 published applications in this corpus.
Search patents in C07C- Granted patents
- 156
- Published applications
- 145
- Assignees
- 128
- Inventors
- 492
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 7 | 0 |
| 1993 | 5 | 0 |
| 1994 | 4 | 0 |
| 1995 | 10 | 0 |
| 1996 | 4 | 0 |
| 1997 | 7 | 0 |
| 1998 | 13 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 5 | 0 |
| 2002 | 6 | 5 |
| 2003 | 4 | 10 |
| 2004 | 2 | 10 |
| 2005 | 3 | 3 |
| 2006 | 5 | 5 |
| 2007 | 2 | 3 |
| 2008 | 2 | 7 |
| 2009 | 2 | 4 |
| 2010 | 3 | 3 |
| 2011 | 6 | 3 |
| 2012 | 0 | 2 |
| 2013 | 1 | 1 |
| 2014 | 1 | 4 |
| 2015 | 2 | 7 |
| 2016 | 5 | 9 |
| 2017 | 8 | 7 |
| 2018 | 5 | 6 |
| 2019 | 6 | 8 |
| 2020 | 4 | 5 |
| 2021 | 5 | 10 |
| 2022 | 2 | 7 |
| 2023 | 7 | 9 |
| 2024 | 1 | 5 |
| 2025 | 6 | 6 |
| 2026 | 3 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Hydroxynorketamine analogues, compositions comprising same and methods of use thereof16 Jun 2026US 12,655,089 B2Spirify Pharma Inc.
- Salts of (2R, 6R)-hydroxynorketamine, their crystal forms, and methods of making the same17 Feb 2026US 12,552,737 B2The United States Government as represented by the Department of Veterans Affairs
- Acyclic lipids and methods of use thereof10 Feb 2026US 12,545,636 B2ReNAgade Therapeutics Management Inc.
- Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine18 Nov 2025US 12,473,251 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Arylcyclohexylamine derivatives and process for preparing same11 Nov 2025US 12,466,782 B2Technische Hochschule KöLn
- Hydroxynorketamine analogues, compositions comprising same and methods of use thereof24 Sep 2026US 2026/0285800 A1Spirify Pharma Inc.
- Synthesis of 2-phenyl-2-amino-cyclohexan-1-one derivatives30 Jul 2026US 2026/0217643 A1
- Small molecules as acaricidal kinin receptor antagonists or mosquitocidal agents7 May 2026US 2026/0123629 A1The Texas A&M University System
- Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods23 Apr 2026US 2026/0109663 A1ACADIA Pharmaceuticals Inc.
- Squaramide derivatives as cb1 allosteric modulators5 Mar 2026US 2026/0062376 A1Research Triangle Institute
Most cited
By later US patents
- Method of using alpha-keto enamine derivatives as ingredients and products incorporating same56US 6,592,884 B2Nestec S. A. · 2003
- Ketamine analogues for treatment of thrombocytopenia45US 5,250,732 AGenentech, Inc. · 1993
- Substituted cyclohexanones38US 7,638,651 B2Auspex Pharmaceuticals, Inc. · 2009
- 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands36US 7,132,445 B2Pharmacopeia Drug Discovery, Inc. · 2006
- Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes34US 5,389,687 AEli Lilly and Company · 1995